• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Valvoline Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    2/6/25 7:00:51 AM ET
    $VVV
    Major Chemicals
    Industrials
    Get the next $VVV alert in real time by email
    vvv-20250206
    0001674910false00016749102025-02-062025-02-06


    UNITED STATES
    SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549
    ____________________

    FORM 8-K
    ___________________

    CURRENT REPORT
    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934
     
    Date of report (Date of earliest event reported): February 6, 2025
    __________________________________
     
    VALVOLINE INC.
    (Exact name of registrant as specified in its charter)
    ___________________________________
    Kentucky 001-37884 30-0939371
    (State or other jurisdiction
    of incorporation)
     
    (Commission
    File Number)
     
    (I.R.S. Employer
    Identification No.)
     
    100 Valvoline Way, Suite 100
    Lexington, Kentucky 40509
    (Address of principal executive offices)

    (859) 357-7777
    (Registrant’s telephone number, including area code)
    ___________________________________

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
    Securities registered pursuant to Section 12(b) of the Act:
    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Common stock, par value $0.01 per shareVVVNew York Stock Exchange
    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
    Emerging growth company☐
    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



    Item 2.02.Results of Operations and Financial Condition
     
    On February 6, 2025, Valvoline Inc. (“Valvoline”) issued a press release ("Press Release") announcing its financial results for the first quarter ended December 31, 2024. A copy of Valvoline's Press Release is attached to this Current Report on Form 8-K (“Form 8-K”) as Exhibit 99.1, which is incorporated by reference into this Item 2.02.

    Item 7.01.Regulation FD Disclosure
     
    On February 6, 2025, Valvoline will make the Press Release available on its website located at http://investors.valvoline.com. On February 6, 2025, Valvoline will make available a webcast and slide presentation relating to the Press Release on Valvoline's website located at http://investors.valvoline.com.

    Item 9.01.Financial Statements and Exhibits
    (d)  Exhibits
    99.1
    Press Release dated February 6, 2025.
    104Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
    In connection with the disclosures set forth in Items 2.02 and 7.01, the information in this Form 8-K, including Exhibit 99.1 attached hereto, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of such section. The information in this Form 8-K, including Exhibit 99.1, shall not be incorporated by reference into any filing under the Securities Act of 1933, as amended, or the Exchange Act, regardless of any incorporation by reference language in any such filing. This Form 8-K will not be deemed an admission as to the materiality of any information in this Form 8-K that is required to be disclosed solely by Regulation FD.





    SIGNATURES
     
    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     
     VALVOLINE INC.
       
    Date: February 6, 2025
    By: /s/ Mary E. Meixelsperger
      Mary E. Meixelsperger
      Chief Financial Officer



    Get the next $VVV alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $VVV

    DatePrice TargetRatingAnalyst
    6/3/2025$45.00Buy
    Goldman
    4/4/2025$40.00Buy
    TD Cowen
    1/21/2025$42.00 → $38.00Overweight → Equal-Weight
    Morgan Stanley
    12/20/2024$42.00Hold
    Stifel
    10/15/2024$49.00Overweight
    Stephens
    8/15/2024$48.00Outperform
    Robert W. Baird
    6/12/2024$49.00Overweight
    Piper Sandler
    3/19/2024$50.00Buy
    Mizuho
    More analyst ratings

    $VVV
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • President & CEO Flees Lori Ann bought $101,353 worth of shares (3,000 units at $33.78), increasing direct ownership by 7% to 46,614 units (SEC Form 4)

      4 - VALVOLINE INC (0001674910) (Issuer)

      5/27/25 4:10:16 PM ET
      $VVV
      Major Chemicals
      Industrials
    • President & CEO Flees Lori Ann bought $99,100 worth of shares (2,500 units at $39.64), converted options into 2,641 shares and covered exercise/tax liability with 1,218 shares, increasing direct ownership by 11% to 39,851 units (SEC Form 4)

      4 - VALVOLINE INC (0001674910) (Issuer)

      12/2/24 4:08:27 PM ET
      $VVV
      Major Chemicals
      Industrials
    • Director Sonsteby Charles M bought $395,000 worth of shares (10,000 units at $39.50), increasing direct ownership by 61% to 26,437 units (SEC Form 4)

      4 - VALVOLINE INC (0001674910) (Issuer)

      11/26/24 4:05:28 PM ET
      $VVV
      Major Chemicals
      Industrials